Get the Stockscreener App
3.365
2.16%
-0.075
Goodrx Holdings Inc stock is traded at $3.365, with a volume of 1.33M.
It is down -2.16% in the last 24 hours and down -20.43% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$3.44
Open:
$3.43
24h Volume:
1.33M
Relative Volume:
0.29
Market Cap:
$331.72M
Revenue:
$775.09M
Net Income/Loss:
$-58.68M
P/E Ratio:
-25.38
EPS:
-0.1326
Net Cash Flow:
$64.06M
1W Performance:
-14.79%
1M Performance:
-20.43%
6M Performance:
-27.31%
1Y Performance:
-45.01%
1-Day Range:
$3.3535
$3.445
1-Week Range:
$3.3535
$3.99
52-Week Range:
$3.305
$6.345
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
3.365 | 1.20B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
290.14 | 46.72B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
89.41 | 14.99B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.31 | 12.33B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.12 | 8.01B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.44 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
Custom watchlist performance reports with GoodRx Holdings Inc.Quarterly Profit Summary & Fast Momentum Entry Tips - newser.com
How analysts rate GoodRx Holdings Inc. stock todayQuarterly Market Review & Verified Technical Trade Signals - newser.com
Institutional scanner results for GoodRx Holdings Inc.July 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Real time social sentiment graph for GoodRx Holdings Inc.Long Setup & Real-Time Buy Signal Notifications - newser.com
Detecting price anomalies in GoodRx Holdings Inc. with AIDividend Hike & Growth Oriented Trading Recommendations - newser.com
Is GoodRx Holdings Inc. meeting your algorithmic filter criteriaTrade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Does GoodRx Holdings Inc. fit your quant trading model2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Risk adjusted return profile for GoodRx Holdings Inc. analyzedTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Smart tools for monitoring GoodRx Holdings Inc.’s price actionJuly 2025 Intraday Action & Short-Term Trading Alerts - newser.com
Measuring GoodRx Holdings Inc.’s beta against major indicesDollar Strength & AI Based Buy and Sell Signals - newser.com
Reversal indicators forming on GoodRx Holdings Inc. stockTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com
Real time breakdown of GoodRx Holdings Inc. stock performanceForecast Cut & Growth-Oriented Investment Plans - newser.com
Does GoodRx Holdings Inc. qualify in momentum factor screeningEarnings Recap Report & Daily Growth Stock Tips - newser.com
Is GoodRx Holdings Inc. still worth holding after the dipWeekly Stock Summary & Expert Approved Momentum Trade Ideas - newser.com
How GoodRx Holdings Inc. stock performs after earningsMarket Movement Recap & High Accuracy Swing Entry Alerts - newser.com
Quantitative breakdown of GoodRx Holdings Inc. recent moveJuly 2025 Sentiment & Entry Point Confirmation Alerts - newser.com
How sentiment analysis helps forecast GoodRx Holdings Inc.Watch List & Technical Buy Zone Confirmation - newser.com
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):